Open report — full analysis, no account required.
Sign up to generate reports and read filings that aren't on the open list.
Get notified when PMI files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsRed Flags Detected
- Delisting (new) — Company faces potential delisting from NYSE American if it fails to regain compliance with listing standards by November 8, 2027.
Picard Medical receives NYSE delisting notices; reports $1.4M equity deficit in Q1 2026
Filed May 21, 2026 · Period ending May 15, 2026 · ~1 min read
Key Changes
-
high
NYSE American issued delisting notice on May 15 for failing to maintain $2M minimum equity; company reported $1.4M deficit of $1.4 million as of March 31, 2026, with losses in all three recent fiscal years.
Item 3.01 verify on EDGAR → -
high
Company must submit compliance plan by June 7, 2026 and regain listing standards by November 8, 2027 or face delisting procedures.
Item 3.01 verify on EDGAR → -
medium
Stock continues trading on NYSE American under symbol 'PMI' but now carries '.BC' designation alerting investors to non-compliance status.
Item 3.01 verify on EDGAR → -
medium
Company announced Q1 2026 financial results for quarter ended March 31, 2026 via press release; detailed results in Exhibit 99.1.
Item 2.02 verify on EDGAR →
Summary
Picard Medical disclosed it received formal delisting notices from NYSE American for falling below minimum stockholders' equity requirements. The company reported a $1.4 million equity deficit of $1.4 million as of March 31, 2026, falling $3.4 million short of the required $2 million minimum. This deficiency follows a pattern of continuing losses across the company's three most recent fiscal years.
The stock now trades with a '.BC' designation signaling non-compliance to investors. The company has until June 7, 2026 to submit a compliance plan and must regain listing standards by November 8, 2027. Failure to submit an acceptable plan, make progress on it, or meet the deadline will trigger formal delisting procedures.
While trading continues normally for now, shareholders face meaningful risk of delisting if the company cannot reverse its negative equity position. Retail investors should watch for the compliance plan submission and any subsequent updates on progress toward regaining positive equity. The company's ability to raise capital, cut costs, or achieve profitability in coming quarters will determine whether it can avoid delisting and remain publicly traded.
Section-by-Section Diff
Event · Item 2.02 — Results of Operations and Financial Condition
Item 2.02 — Results of Operations and Financial Condition filed; see Key Changes for terms.
Added in current filing · verify on EDGAR →
In a press release dated May 21, 2026, Picard Medical, Inc. (the “Company”) announced financial results for the Company’s first quarter ended March 31, 2026.
The company disclosed its first quarter 2026 financial results ending March 31, 2026 through a press release. The actual financial details are contained in Exhibit 99.1, which is not included in this 8-K body text.
Event · Item 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule
Picard Medical received NYSE American delisting notices for failing stockholders' equity and market value standards; must submit compliance plan by June 7, 2026.
Added in current filing · verify on EDGAR →
In connection with the Notices, the Company must submit a plan (the “Plan”) to the NYSE American by June 7, 2026, advising of actions it has taken or will take to regain compliance with the continued listing standards by November 8, 2027.
The company has until June 7, 2026 to submit a compliance plan to NYSE American and must regain compliance with listing standards by November 8, 2027. If the plan is not submitted, not accepted, or the company fails to make progress consistent with the plan, it will be subject to delisting procedures. The company is currently preparing its plan to meet the June 7 deadline.
Added in current filing · verify on EDGAR →
The Notice has no immediate effect on the listing or trading of the Company’s common stock, which will continue to trade on the NYSE American under the symbol “PMI” with the added designation of “.BC” (which was applied following the May 8 Notice).
The company's stock continues to trade on NYSE American under symbol "PMI" but now carries the ".BC" designation, which was added following the earlier May 8 notice. This designation alerts investors to the company's non-compliance status. The notices do not affect ongoing business operations or SEC reporting requirements.
Event · Item 7.01 — Regulation FD Disclosure
Company received notices from exchange regarding failure to meet continued listing standards.
Added in current filing · verify on EDGAR →
the Company issued a press release disclosing receipt of the Notices and the specific continued listing standards that the Company has fallen below
Picard Medical disclosed it received formal notices from its stock exchange indicating the company has fallen below certain continued listing standards. The specific standards violated are detailed in the attached press release (Exhibit 99.1). This is a regulatory compliance issue that could lead to delisting if not remedied within the exchange's cure period.
Event · Item 9.01 — Financial Statements and Exhibits
Picard Medical filed an 8-K attaching a press release dated May 21, 2026; no material event details disclosed in the filing body.
Show 1 minor / wording change
Added in current filing · verify on EDGAR →
The following exhibits are being filed herewith: | Exhibit No. | Description | 99.1 | Press Release, dated May 21, 2026.
The 8-K attaches a press release dated May 21, 2026 as Exhibit 99.1. The filing body does not disclose the content or subject matter of the press release, so the nature of the event being announced cannot be determined from this 8-K text alone.
Thanks — your feedback helps us improve report quality.
Figures/quotes linked to EDGAR · Narrative written by AI · Jun 1, 2026 · How we verify